Home / Norepinephrine / Sweden
SE ATC C01CA03 · updated 2 Nov 2026
Norepinephrine shortage in Sweden
Is there a Norepinephrine shortage in Sweden?
Yes. As of 2 Nov 2026, 3 Norepinephrine products are reported short in Sweden, the first since 28 Nov 2025. The company estimate for the return is 15 Nov 2026 (latest 15 Jan 2027). Main reason: not stated.
Also short in Canada, Belgium, Czechia, New Zealand. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Noradrenalin Pfizer 1 mg/ml Ampull, 5 x 2 ml | Pfizer AB | 28 Nov 2025 | 18 Dec 2026 | Not stated |
| SE | Noradrenalin Kalceks 1 mg/ml Ampull, 10 x 2 ml | AS KALCEKS | 1 Jun 2026 | 15 Nov 2026 | Not stated |
| SE | Noradrenalin Fresenius Kabi 1 mg/ml Ampull, 10 x 4 ml anticipated | Fresenius Kabi AB | 27 Nov 2026 | 15 Jan 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.